428 related articles for article (PubMed ID: 27932455)
41. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
[No Abstract] [Full Text] [Related]
42. Global transcriptional activity dynamics reveal functional enhancer RNAs.
Kim YJ; Xie P; Cao L; Zhang MQ; Kim TH
Genome Res; 2018 Dec; 28(12):1799-1811. PubMed ID: 30352805
[TBL] [Abstract][Full Text] [Related]
43. Mechanistic analysis of enhancer sequences in the estrogen receptor transcriptional program.
Tabe-Bordbar S; Song YJ; Lunt BJ; Alavi Z; Prasanth KV; Sinha S
Commun Biol; 2024 Jun; 7(1):719. PubMed ID: 38862711
[TBL] [Abstract][Full Text] [Related]
44. Enhancer RNAs Mediate Estrogen-Induced Decommissioning of Selective Enhancers by Recruiting ERα and Its Cofactor.
Yang M; Lee JH; Zhang Z; De La Rosa R; Bi M; Tan Y; Liao Y; Hong J; Du B; Wu Y; Scheirer J; Hong T; Li W; Fei T; Hsieh CL; Liu Z; Li W; Rosenfeld MG; Xu K
Cell Rep; 2020 Jun; 31(12):107803. PubMed ID: 32579929
[TBL] [Abstract][Full Text] [Related]
45. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.
Lee JH; Xiong F; Li W
RNA Biol; 2020 Nov; 17(11):1550-1559. PubMed ID: 31916476
[TBL] [Abstract][Full Text] [Related]
46. SRC-3 Coactivator Governs Dynamic Estrogen-Induced Chromatin Looping Interactions during Transcription.
Panigrahi AK; Foulds CE; Lanz RB; Hamilton RA; Yi P; Lonard DM; Tsai MJ; Tsai SY; O'Malley BW
Mol Cell; 2018 May; 70(4):679-694.e7. PubMed ID: 29775582
[TBL] [Abstract][Full Text] [Related]
47. Enhancer-promoter entanglement explains their transcriptional interdependence.
Panigrahi AK; Lonard DM; O'Malley BW
Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2216436120. PubMed ID: 36656865
[TBL] [Abstract][Full Text] [Related]
48. The current research status of enhancer RNAs.
Cheng X; Yang Q; Tan ZD; Tan Y; Pu H; Zhao X; Zhang SH; Zhu L
Yi Chuan; 2017 Sep; 39(9):784-797. PubMed ID: 28936977
[TBL] [Abstract][Full Text] [Related]
49. Enhancer RNAs stimulate Pol II pause release by harnessing multivalent interactions to NELF.
Gorbovytska V; Kim SK; Kuybu F; Götze M; Um D; Kang K; Pittroff A; Brennecke T; Schneider LM; Leitner A; Kim TK; Kuhn CD
Nat Commun; 2022 May; 13(1):2429. PubMed ID: 35508485
[TBL] [Abstract][Full Text] [Related]
50. Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program.
Tan Y; Jin C; Ma W; Hu Y; Tanasa B; Oh S; Gamliel A; Ma Q; Yao L; Zhang J; Ohgi K; Liu W; Aggarwal AK; Rosenfeld MG
Mol Cell; 2018 Aug; 71(4):526-539.e8. PubMed ID: 30118678
[TBL] [Abstract][Full Text] [Related]
51. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.
Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661
[TBL] [Abstract][Full Text] [Related]
52. Visualization of Enhancer-Derived Noncoding RNA.
Shibayama Y; Fanucchi S; Mhlanga MM
Methods Mol Biol; 2017; 1468():19-32. PubMed ID: 27662867
[TBL] [Abstract][Full Text] [Related]
53. Lingering Questions about Enhancer RNA and Enhancer Transcription-Coupled Genomic Instability.
Rothschild G; Basu U
Trends Genet; 2017 Feb; 33(2):143-154. PubMed ID: 28087167
[TBL] [Abstract][Full Text] [Related]
54. Identification and Functional Characterization of Two Noncoding RNAs Transcribed from Putative Active Enhancers in Hepatocellular Carcinoma.
Lee YE; Lee J; Lee YS; Jang JJ; Woo H; Choi HI; Chai YG; Kim TK; Kim T; Kim LK; Choi SS
Mol Cells; 2021 Sep; 44(9):658-669. PubMed ID: 34588321
[TBL] [Abstract][Full Text] [Related]
55. Enhancer RNAs predict enhancer-gene regulatory links and are critical for enhancer function in neuronal systems.
Carullo NVN; Phillips Iii RA; Simon RC; Soto SAR; Hinds JE; Salisbury AJ; Revanna JS; Bunner KD; Ianov L; Sultan FA; Savell KE; Gersbach CA; Day JJ
Nucleic Acids Res; 2020 Sep; 48(17):9550-9570. PubMed ID: 32810208
[TBL] [Abstract][Full Text] [Related]
56. Establishment of active chromatin structure at enhancer elements by mixed-lineage leukemia 1 to initiate estrogen-dependent gene expression.
Jeong KW; Andreu-Vieyra C; You JS; Jones PA; Stallcup MR
Nucleic Acids Res; 2014 Feb; 42(4):2245-56. PubMed ID: 24288367
[TBL] [Abstract][Full Text] [Related]
57. Altered enhancer transcription underlies Huntington's disease striatal transcriptional signature.
Le Gras S; Keime C; Anthony A; Lotz C; De Longprez L; Brouillet E; Cassel JC; Boutillier AL; Merienne K
Sci Rep; 2017 Feb; 7():42875. PubMed ID: 28225006
[TBL] [Abstract][Full Text] [Related]
58. Enhancer RNA (eRNA) in Human Diseases.
Wang Y; Zhang C; Wang Y; Liu X; Zhang Z
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232885
[TBL] [Abstract][Full Text] [Related]
59. eRNAbase: a comprehensive database for decoding the regulatory eRNAs in human and mouse.
Song C; Zhang G; Mu X; Feng C; Zhang Q; Song S; Zhang Y; Yin M; Zhang H; Tang H; Li C
Nucleic Acids Res; 2024 Jan; 52(D1):D81-D91. PubMed ID: 37889077
[TBL] [Abstract][Full Text] [Related]
60. Integrator mediates the biogenesis of enhancer RNAs.
Lai F; Gardini A; Zhang A; Shiekhattar R
Nature; 2015 Sep; 525(7569):399-403. PubMed ID: 26308897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
